Cote d'Ivoire: Market for Medicaments Containing Insulin But Not Antibiotics In Measured Doses 2025

Market Size for Medicaments Containing Insulin But Not Antibiotics In Measured Doses in Cote d'Ivoire

The Cote d'Ivoire's prophylactic medicaments containing insulin market rose notably to $X in 2022, with an increase of 6.3% against the previous year. This figure reflects the total revenues of producers and importers (excluding logistics costs, retail marketing costs, and retailers' margins, which will be included in the final consumer price). Over the period under review, consumption saw significant growth. As a result, consumption attained the peak level of $X. From 2021 to 2022, the growth of the market failed to regain momentum.

Exports of Medicaments Containing Insulin But Not Antibiotics In Measured Doses

Exports from Cote d'Ivoire

In 2020, prophylactic medicaments containing insulin exports from Cote d'Ivoire skyrocketed to X kg, picking up by 117% compared with the previous year. In general, exports enjoyed a significant increase. The exports peaked at X kg in 2018; however, from 2019 to 2020, the exports remained at a lower figure.

In value terms, prophylactic medicaments containing insulin exports surged to $X in 2020. Overall, exports saw a strong expansion. Over the period under review, the exports hit record highs at $X in 2018; however, from 2019 to 2020, the exports remained at a lower figure.

Exports by Country

Ghana (X kg) was the main destination for prophylactic medicaments containing insulin exports from Cote d'Ivoire, accounting for a approx. 100% share of total exports.

From 2014 to 2020, the average annual rate of growth in terms of volume to Ghana was relatively modest.

In value terms, Ghana ($X) emerged as the key foreign market for medicaments containing insulin but not antibiotics in measured doses exports from Cote d'Ivoire.

From 2014 to 2020, the average annual growth rate of value to Ghana was relatively modest.

Export Prices by Country

The average prophylactic medicaments containing insulin export price stood at $X per ton in 2020, declining by -26.8% against the previous year. Overall, the export price showed a abrupt slump. The pace of growth was the most pronounced in 2019 a decrease of -24.4% against the previous year. Over the period under review, the average export prices hit record highs at $X per ton in 2014; however, from 2015 to 2020, the export prices failed to regain momentum.

As there is only one major export destination, the average price level is determined by prices for Ghana.

From 2014 to 2020, the rate of growth in terms of prices for Ghana amounted to 0.0% per year.

Imports of Medicaments Containing Insulin But Not Antibiotics In Measured Doses

Imports into Cote d'Ivoire

In 2022, the amount of medicaments containing insulin but not antibiotics in measured doses imported into Cote d'Ivoire rose rapidly to X tons, surging by 8.3% compared with the previous year's figure. Overall, imports showed a significant increase. The pace of growth was the most pronounced in 2020 with an increase of 254% against the previous year. As a result, imports attained the peak of X tons. From 2021 to 2022, the growth of imports failed to regain momentum.

In value terms, prophylactic medicaments containing insulin imports reached $X in 2022. Over the period under review, imports saw a significant expansion. The pace of growth appeared the most rapid in 2020 with an increase of 248% against the previous year. As a result, imports reached the peak of $X. From 2021 to 2022, the growth of imports failed to regain momentum.

Imports by Country

France (X tons), Denmark (X tons) and Germany (X tons) were the main suppliers of prophylactic medicaments containing insulin imports to Cote d'Ivoire, together accounting for 97% of total imports.

From 2012 to 2022, the most notable rate of growth in terms of purchases, amongst the main suppliers, was attained by Germany (with a CAGR of +56.6%), while imports for the other leaders experienced more modest paces of growth.

In value terms, the largest prophylactic medicaments containing insulin suppliers to Cote d'Ivoire were France ($X), Denmark ($X) and Germany ($X), together comprising 96% of total imports.

In terms of the main suppliers, Germany, with a CAGR of +56.5%, recorded the highest growth rate of the value of imports, over the period under review, while purchases for the other leaders experienced more modest paces of growth.

Import Prices by Country

The average prophylactic medicaments containing insulin import price stood at $X per ton in 2022, reducing by -4.3% against the previous year. Over the period under review, import price indicated measured growth from 2012 to 2022: its price increased at an average annual rate of +2.1% over the last decade. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2022 figures, prophylactic medicaments containing insulin import price increased by +4.2% against 2020 indices. The pace of growth was the most pronounced in 2013 an increase of 83% against the previous year. Over the period under review, average import prices reached the peak figure at $X per ton in 2014; however, from 2015 to 2022, import prices failed to regain momentum.

There were significant differences in the average prices amongst the major supplying countries. In 2022, amid the top importers, the country with the highest price was Morocco ($X per ton), while the price for India ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by Morocco (+4.6%), while the prices for the other major suppliers experienced mixed trend patterns.

Source: IndexBox Platform